Abstract: Nanodispersed manganese oxide is a unique substance with a high application potential in nanoelectronics and nanooptics. The scientific literature contains little information about the biological effects and toxic action of this substance after it enters a human body. The biological effects were studied in Wistar rats after intragastric administration of manganese oxide for 30 days. The effects included loss in the body mass, activation of oxidation processes (increased level of lipid hydroperoxides, MDA in the blood serum), decrease in the antioxidant activity (inhibited antioxidant activity in the blood serum), damaged hepatocyte membranes (higher serum AST and ALT levels), and protein synthesizing liver function abnormalities (low albumins, high gamma globulins in the blood serum).
INTRODUCTION
Today nanomaterials are increasingly coming into contact with people especially the most commonly used metal oxide particles. Because of their physical and chemical properties, metal oxides including manganese oxide powder can pose health and safety threats. This compound is widely used in templates for the production of nanomagnetic, sorbing materials, nanocatalysts, and semi-conducting thermistors [1, 2] . Manufacturing plants involved in such production processes can become the source of nanopowder emission to air, water, and soil. As a result, the local community is exposed to drinking water and agricultural produce contaminated with nanodispersed manganese oxide [3] .
Recent research has shown that human exposure to environmental contaminants, including manganese nanoparticles, is recognized as a significant contributing factor for the development of Parkinson's disease [4] .
For that reason, it is essential to study the biological effects and toxic action of nanodispersed manganese oxide after peroral intake.
Research
shows that metal nanoparticles synthesized by different methods may be used as antibacterial agents [5, 6] ; this requires a more thorough analysis of the biological effects of manganese oxide nanoparticles which due to their cytotoxic properties may be also used as bactericidal agents [7] . Accumulated material of the negative effects of manganese oxide nanoparticles in inhalation. As a priority is marked neurotoxic effect [7] [8] [9] [10] . One of the pronounced effects associated with the intake of nanoparticles of a number of metals and nonmetals is hepatotoxicity the symptoms of which include changes in enzyme activity, apoptosis activation and finestructure changes of the hepatocytes and Kupffer cells [11, 12] . Earlier in-house research showed that the one-dose delivery of manganese oxide in aqueous suspension (200 mg/kg) intragastrically administered to mice leads to structural changes in the liver and kidney. Pathomorphology here takes the form of dilation of the venous vessels and proliferation of adenoid tissue [13, 14] .
The purpose of this research is to investigate the biological effects of nanodispersed manganese oxide in Wistar rats after intragastrical administration of the aqueous suspension for 30 days.
MATERIALS AND METHODS

Materials
The aqueous suspension of nanodispersed manganese oxide was purchased from the Laboratory of Multiphase Dispersed Systems, Institute of Technical Chemistry at the Ural Research Center of the Russian Academy of Sciences. The investigated substance was synthesized by the template synthesis method according to the procedures presented in these articles [6, 7] . The size of the nanodispersed manganese oxide particles ranged from 24 to 70 nm, and the specific surface area was about 150 m 2 / . The particles had a non-spherical acicular shape.
Serum alanine aminotransferase (ALT) and aspartate transaminase (AST) activities were measured by the kits from Human, Germany; albumin and gamma globulin concentrations were measured by the kits from Helena, UK; lipid peroxide concentration and anti-oxidant activity in the serum were measured by the kits from BioChimMak, Russia.
Experimental Animals
Fifty mature Wistar male rats were obtained for this study from the federal state Biomedical Technology Research Center of the Russian Academy of Medical Sciences. The body weight of the rats averaged 220±15 g. All rats were maintained in polypropylene cages of standard dimensions in a ventilated room at a constant temperature of 23.0±2.0 ºC and humidity of 60.0±5.0 %; the rats were housed in groups of 2 rats per cage. The rats were fed a semisynthetic diet with the nutritional and biological values in accordance with the recommended norm of physiological requirements. Access to food was not limited. All procedures and studies were approved by the Animal Care Ethical Committee at the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies.
Experimental Procedure
The animals were divided into 5 groups (10 animals each). The experimental rats in groups 1, 2, 3 and 4 received manganese oxide in aqueous suspension administered intragastrically for 30 days at doses of 234.0 mg/kg, 46.8 mg/kg, 9.4 mg/kg and 4.7 mg/kg which corresponds to the lethal doses of 1/10. 1/50. 1/250. 1/500 LD 50 . The control group 5 kept in the same environmental conditions was administered distilled water. The volume of water and experimental substance administered to the animals did not exceed 1.0 ml.
The following parameters were studied during the experiment: the survival rate, the body weight before the experiment (base level), on the 10 
Determining the Values of Serum Biochemistry
The values of serum biochemistry including ALT and AST were measured with the kits following the guidelines for the automatic biochemical analyzer (Konelab20. Thermo Scientific, Finland The plasma MDA levels were measured in accordance with the methodological procedure. Tris Buffer in the amount of 1.7 ml was added to 300 mcl of serum in a centrifuge tube; 0.5 ml of 34% trichloroacetic acid (TCA) was used to precipitate proteins. Then the precipitation was purified in a centrifuge tube for 10 min at 300 rpm -20 min. The supernatant fluid was later transferred into tubes, 2 ml at a time, and mixed with 1 ml of 0.8% TCA aqueous suspension, the generated samples were placed into the boiling water bath for 10 min. The samples containing Tris-Buffer-HCl instead of the supernatant fluid were used as control samples. After the samples turned pink, they were cooled down to room temperature, and the measurements of the optical density (OD) were taken at 532 nm in a tray, 10 mm ray path length, against the control sample using a spectrophotometer PE-5300 (Ekros, Russia). MDA concentration was determined by using a molar extinction coefficient according to the formula OD*156=mcM/ml.
Data Analysis
The data was analyzed with Statistica 6.0 data analysis software. The results were analyzed with parametric statistical methods. Student's t-test was used to ensure the accuracy of results. For the results, the P values less than or equal to 0.05 were considered statistically significant.
RESULTS
Nanodispersed Manganese Oxide Effects on the Body Weight Change in the Experimental Animals
The analysis of the body weight change in the experimental animals determined a 7.7% decrease in the body weight in group 1 by the 10 th day. The base weight was re-gained by the 30 th day. The body weight decrease in the animals of this group during the course of the experiment was significantly different from the control group values. In other groups, the body weight in the experimental animals increased ( Table 1) .
Nanodispersed Manganese Oxide Effects on the Oxidation and Anti-Oxidant Processes
Assessment of the oxidation and anti-oxidation processes in the experimental animals determined that in groups 1-3 the level of lipid peroxides was 1.5 -2 times higher ( <0.05) and the plasma MDA levels were 1.7 -2 times higher ( <0.05) as compared to the base line and the control group. A significant reduction in the AOS levels as compared to the base level and the control values was registered in groups 1 -3 ( <0.05).
Nevertheless, the maximum indicator reduction (by 5.1 times as compared to the control group, and by 5.5 times as compared to the base level) was registered in group 1. The minimum AOS level reduction (by 2.4 times as compared to the control group, and by 2.5 times as compared to the base level) was registered in group 3. See Figure 1 , Table 2 .
Nanodispersed Manganese Dioxide Effects on the Liver Cells Membranes
A significantly higher plasma AST level was registered in group 1 as compared to the base and control levels ( <0.05). A higher serum ALT level was Table 3 .
Imbalance in serum protein levels points to a change in the protein synthesizing liver function. A significant decrease in serum albumin concentrations ( <0.05) was registered in groups 1. A higher serum gamma globulin level (a 1.6 time increase as compared to the base level, and a 1.5 time increase as compared to the control level) was registered in group 1 ( Figure   3 , Table 3 ).
DISCUSSION
These registered effects give evidence to a possible negative impact that the studied nanodispersed manganese oxide suspension has on the experimental animals after intragastric administration for 30 days at the doses of 234.0 mg/kg, 46.8 mg/kg, 9.4 mg/kg. After administration of the suspension at a dose of 4.7 mg/kg for 30 days, no significant change was registered in the studied indicators as compared to the base and control levels.
Compilation of the test data allows us to draw conclusions in regards to a possible toxic action of the studied particles. Activation of lipid peroxidation following a direct cytotoxic impact by nanodispersed manganese oxide (typical of metals and their compounds) could serve as a possible trigger [8] . This effect develops on the system level of the lipid hydroperoxide and MDA (its product) levels build-up which results in inhibited antioxidant processes. In the course of our study, we determined that hepatocytes are the target cells for the tested compound after peroral intake. The reason for this, first of all, is the intake method -peroral -which is connected with the functional activity of the liver cells involved in detoxification processes. It is necessary to take into account a high penetration power of the metal nanoparticles [9] which can intensify the contact of the particles with the target cells. Hepatocyte damage intensifies transaminase inflow in the general circulation and results in reduced protein synthesizing liver function which is reflected in a higher AST and ALT activity, reduced albumin concentrations, and increased gamma globulin concentrations in the blood serum [10] . Therefore, the biological effects of the aqueous suspension of nanodispersed manganese oxide after daily intragastric administration to Wistar rats for 30 days include reduced body weight (at a dose of 234.0 mg/kg), activation of oxidation processes connected to higher serum lipid hydroperoxides and plasma MDA (at a dose of 9.4 mg/kg), a lower antioxidant activity connected to lower serum AOS level (at a dose of 9.4 mg/kg), liver cell membrane damage connected to higher serum AST (at a dose of 234.0 mg/kg) and ALT levels (at a dose of 9.4 mg/kg), a liver protein synthesizing function disorder connected to lower albumin concentrations (at a dose of 9.4 mg/kg), and higher serum gamma globulin concentrations (at a dose of 234.0 mg/kg).
